Endothelin-1 is considered a predictor of adverse clinical outcomes in HF and plays a key role in many aspects of cardiac physiology and pathology, such as hypertension, cardiac contractility, and cardiac remodeling [32, 33]. Here, EDN1 is linked to Hypertension.